Task: Answer the multiple-choice question.
Query: Which drug exhibits a -3.861\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a: CCOC(=O)c1c(C)c(C(=O)N2CCCCCC2)c(C)n1CC
b: Cc1csc(NC(=O)Cc2ccccc2[N+](=O)[O-])n1
c: COc1ccc(C2=NN(CCC(=O)NCc3cccs3)C(=O)CC2)cc1
Answer: c. COc1ccc(C2=NN(CCC(=O)NCc3cccs3)C(=O)CC2)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1ccc(C2=NN(CCC(=O)NCc3cccs3)C(=O)CC2)cc1
COc1ccc(C2=NN(CCC(=O)NCc3cccs3)C(=O)CC2)cc1
3-[6-(4-methoxyphenyl)-3-oxo-4,5-dihydropyridazin-2-yl]-N-(thiophen-2-ylmethyl)propanamide